413
Views
0
CrossRef citations to date
0
Altmetric
Invited Reviews

Establishing optimal cutoff values for high-sensitivity cardiac troponin algorithms in risk stratification of acute myocardial infarction

&
Pages 1-22 | Received 31 Mar 2023, Accepted 07 Jul 2023, Published online: 19 Jul 2023

References

  • Blomkalns AL, Gibler WB. Chest pain unit concept: rationale and diagnostic strategies. Cardiol Clin. 2005;23(4):411–421. doi: 10.1016/j.ccl.2005.08.011.
  • Niska R, Bhuiya F, Xu J. National hospital ambulatory medical care survey: 2007 emergency department summary. Natl Health Stat Report. 2010;6(26):1–31.
  • Haasenritter J, Stanze D, Widera G, et al. Does the patient with chest pain have a coronary heart disease? Diagnostic value of single symptoms and signs–a meta-analysis. Croat Med J. 2012;53(5):432–441. doi: 10.3325/cmj.2012.53.432.
  • Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58(1):54–61. doi: 10.1373/clinchem.2011.165795.
  • Kavsak PA, MacRae AR, Yerna MJ, et al. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2009;55(3):573–577. doi: 10.1373/clinchem.2008.116020.
  • Wu AHB, Christenson RH, Greene DN, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American Association for Clinical Chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine. Clin Chem. 2018;64(4):645–655. doi: 10.1373/clinchem.2017.277186.
  • Eggers KM, Lind L, Venge P, et al. Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? Am J Cardiol. 2009;103(5):588–591. doi: 10.1016/j.amjcard.2008.11.007.
  • Lippi G, Montagnana M, Guidi GC. The clinical dilemma of positive results of high-sensitive troponin assays. Am J Cardiol. 2009;103(9):1332. doi: 10.1016/j.amjcard.2009.02.037.
  • Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–867. doi: 10.1056/NEJMoa0900428.
  • Christ M, Popp S, Pohlmann H, et al. Implementation of high sensitivity cardiac troponin T measurement in the emergency department. Am J Med. 2010;123(12):1134–1142. doi: 10.1016/j.amjmed.2010.07.015.
  • Latini R, Masson S, Anand IS, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116(11):1242–1249. doi: 10.1161/CIRCULATIONAHA.106.655076.
  • Vickers AJ, Lilja H. Cutpoints in clinical chemistry: time for fundamental reassessment. Clin Chem. 2009;55(1):15–17. doi: 10.1373/clinchem.2008.114694.
  • Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined–a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–969. doi: 10.1016/s0735-1097(00)00804-4.
  • Apple FS, Jaffe AS, Collinson P, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2015;48(4–5):201–203. doi: 10.1016/j.clinbiochem.2014.08.021.
  • Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53(4):552–574. doi: 10.1373/clinchem.2006.084194.
  • Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23(23):1809–1840. doi: 10.1053/euhj.2002.3385.
  • Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American college of cardiology/American heart association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol. 2000;36(3):970–1062. doi: 10.1016/s0735-1097(00)00889-5.
  • Aldous SJ, Florkowski CM, Crozier IG, et al. Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann Clin Biochem. 2011;48(Pt 3):241–248. doi: 10.1258/acb.2010.010219.
  • Aldous SJ, Richards AM, Cullen L, et al. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem. 2011;57(8):1154–1160. doi: 10.1373/clinchem.2010.161166.
  • Hammerer-Lercher A, Ploner T, Neururer S, et al. High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice? J Am Heart Assoc. 2013;2(3):e000204. doi: 10.1161/JAHA.113.000204.
  • Melki D, Lind S, Agewall S, et al. Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations. Scand Cardiovasc J. 2011;45(4):198–204. doi: 10.3109/14017431.2011.565792.
  • Santaló M, Martin A, Velilla J, et al. Using high-sensitivity troponin T: the importance of the proper gold standard. Am J Med. 2013;126(8):709–717. doi: 10.1016/j.amjmed.2013.03.003.
  • Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem. 2010;56(4):642–650. doi: 10.1373/clinchem.2009.134460.
  • Aldous SJ, Richards M, Cullen L, et al. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ. 2012;184(5):E260–8. doi: 10.1503/cmaj.110773.
  • Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306(24):2684–2693. doi: 10.1001/jama.2011.1896.
  • Zhelev Z, Hyde C, Youngman E, et al. Diagnostic accuracy of single baseline measurement of elecsys troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ. 2015;350:h15. doi: 10.1136/bmj.h15.
  • Pickering JW, Than MP, Cullen L, et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med. 2017;166(10):715–724. doi: 10.7326/M16-2562.
  • Chapman AR, Sandeman D, Ferry AV, et al. Risk stratification using high-sensitivity cardiac troponin T in patients with suspected acute coronary syndrome. J Am Coll Cardiol. 2020;75(8):985–987. doi: 10.1016/j.jacc.2019.12.036.
  • Carlton EW, Ingram J, Taylor H, et al. Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial. Heart. 2020;106(20):1586–1594. doi: 10.1136/heartjnl-2020-316692.
  • Chew DP, Lambrakis K, Blyth A, et al. A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department with high-sensitivity troponin T study (RAPID-TnT). Circulation. 2019;140(19):1543–1556. doi: 10.1161/CIRCULATIONAHA.119.042891.
  • Shah AS, Anand A, Sandoval Y, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015;386(10012):2481–2488. doi: 10.1016/S0140-6736(15)00391-8.
  • Chapman AR, Lee KK, McAllister DA, et al. Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA. 2017;318(19):1913–1924. doi: 10.1001/jama.2017.17488.
  • Anand A, Lee KK, Chapman AR, et al. High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial. Circulation. 2021;143(23):2214–2224. doi: 10.1161/CIRCULATIONAHA.120.052380.
  • Neumann JT, Sörensen NA, Schwemer T, et al. Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. JAMA Cardiol. 2016;1(4):397–404. doi: 10.1001/jamacardio.2016.0695.
  • Chapman AR, Stewart S, Mills NL. Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome. Heart. 2019;105(10):740–741. doi: 10.1136/heartjnl-2018-314306.
  • Sandoval Y, Nowak R, deFilippi CR, et al. Myocardial infarction risk stratification with a single measurement of high-sensitivity troponin I. J Am Coll Cardiol. 2019;74(3):271–282. doi: 10.1016/j.jacc.2019.05.058.
  • Sandoval Y, Smith SW, Love SA, et al. Single high-sensitivity cardiac troponin I to rule out acute myocardial infarction. Am J Med. 2017;130(9):1076–1083.e1. doi: 10.1016/j.amjmed.2017.02.032.
  • Greenslade J, Cho E, Van Hise C, et al. Evaluating rapid rule-out of acute myocardial infarction using a high-sensitivity cardiac troponin I assay at presentation. Clin Chem. 2018;64(5):820–829. doi: 10.1373/clinchem.2017.283887.
  • Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem. 1974;20(12):1535–1542. doi: 10.1093/clinchem/20.12.1535.
  • Vasile VC, Saenger AK, Kroning JM, et al. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56(7):1086–1090. doi: 10.1373/clinchem.2009.140616.
  • Aakre KM, Røraas T, Petersen PH, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem. 2014;60(6):838–847. doi: 10.1373/clinchem.2013.216978.
  • Nordenskjöld AM, Ahlström H, Eggers KM, et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem. 2013;59(2):401–409. doi: 10.1373/clinchem.2012.191700.
  • Wu AH, Lu QA, Todd J, et al. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem. 2009;55(1):52–58. doi: 10.1373/clinchem.2008.107391.
  • van der Linden N, Hilderink JM, Cornelis T, et al. Twenty-four-hour biological variation profiles of cardiac troponin I in individuals with or without chronic kidney disease. Clin Chem. 2017;63(10):1655–1656. doi: 10.1373/clinchem.2017.275107.
  • Simpson AJ, Potter JM, Koerbin G, et al. Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values. Clin Chem. 2014;60(6):848–854. doi: 10.1373/clinchem.2013.219410.
  • Goldberg J, Iriarte B, Prostko J, et al. Short and long-term biological variability of troponin I determined using the ARCHITECT STAT high sensitive troponin I assay. Clin Chem. 2011;57: A97.
  • Apple F, Murakami M, Wians F, et al. Short-term biological variation of cardiac troponin I measured with three high-sensitivity assays. Clin Chem. 2011;57:C05.
  • Lan NSR, Nguyen LT, Vasikaran SD, et al. Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy. Clin Chem Lab Med. 2020;58(11):1941–1949. doi: 10.1515/cclm-2020-0046.
  • Zaninotto M, Padoan A, Mion MM, et al. Short-term biological variation and diurnal rhythm of cardiac troponin I (access hs-TnI) in healthy subjects. Clin Chim Acta. 2020;504:163–167. doi: 10.1016/j.cca.2020.02.004.
  • Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124(2):136–145. doi: 10.1161/CIRCULATIONAHA.111.023937.
  • Liu L, Consagra W, Cai X, et al. Sex-specific absolute Delta thresholds for high-sensitivity cardiac troponin T. Clin Chem. 2022;68(3):441–449. doi: 10.1093/clinchem/hvab230.
  • Shah ASV, Sandoval Y, Noaman A, et al. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ. 2017;359:j4788. doi: 10.1136/bmj.j4788.
  • Lee KK, Noaman A, Vaswani A, et al. Prevalence, determinants, and clinical associations of high-sensitivity cardiac troponin in patients attending emergency departments. Am J Med. 2019;132(1):110.e8–110.e21. doi: 10.1016/j.amjmed.2018.10.002.
  • Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American college of cardiology foundation task force on clinical expert consensus documents. J Am Coll Cardiol. 2012;60(23):2427–2463. doi: 10.1016/j.jacc.2012.08.969.
  • Shah AS, McAllister DA, Mills R, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med. 2015;128(5):493–501.e3. doi: 10.1016/j.amjmed.2014.10.056.
  • Chapman AR, Shah ASV, Lee KK, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137(12):1236–1245. doi: 10.1161/CIRCULATIONAHA.117.031806.
  • Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96(5):644–647. doi: 10.1111/j.1651-2227.2006.00178.x.
  • Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670–675. doi: 10.1093/aje/kwj063.
  • Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med. 2016;26(3):297–307. doi: 10.11613/BM.2016.034.
  • Ray P, Le Manach Y, Riou B, et al. Statistical evaluation of a biomarker. Anesthesiology. 2010;112(4):1023–1040. doi: 10.1097/ALN.0b013e3181d47604.
  • Hastie T, Tibshirani R, Friedman JH. Chapter 9: additive models, trees, and related methods. In: Hastie T, Tibshirani R, Friedman JH, eds. The elements of statistical learning. Data mining, inference, and prediction. 2nd ed. New York (NY): Springer; 2009: pp. 305–317.
  • Hayes T, Usami S, Jacobucci R, et al. Using classification and regression trees (CART) and random forests to analyze attrition: results from two simulations. Psychol Aging. 2015;30(4):911–929. doi: 10.1037/pag0000046.
  • Dalton BR, Krishnan A, Stewart JJ, et al. Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies: insights from data simulation. Clin Microbiol Infect. 2021;27(11):1701–1703. doi: 10.1016/j.cmi.2021.07.028.
  • Boehmke B, Greenwell B. Chapter 9: decision trees and chapter 10: bagging. In: Boehmke B, Greenwell B, eds. Hands-on machine learning with R. New York (NY): Chapman and Hall/CRC; 2019: pp. 175–200.
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. doi: 10.1093/eurheartj/ehv320.
  • Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999–3054. doi: 10.1093/eurheartj/ehr236.
  • Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33(18):2252–2257. doi: 10.1093/eurheartj/ehs154.
  • Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525–2538. doi: 10.1093/eurheartj/ehm355.
  • Wu AH, Jaffe AS, Apple FS, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007;53(12):2086–2096. doi: 10.1373/clinchem.2007.095679.
  • Pickering JW, Greenslade JH, Cullen L, et al. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart. 2016;102(16):1270–1278. doi: 10.1136/heartjnl-2015-308505.
  • Chapman AR, Anand A, Boeddinghaus J, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation. 2017;135(17):1586–1596. doi: 10.1161/CIRCULATIONAHA.116.025021.
  • Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem. 2012;58(1):209–218. doi: 10.1373/clinchem.2011.171827.
  • Kavsak PA, MacRae AR. Letter by Kavsak and MacRae regarding article, utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2012;125(6):e358. doi: 10.1161/CIRCULATIONAHA.111.057885.
  • Kavsak PA, Ko DT, Wang X, et al. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin Chem. 2010;56(12):1902–1904. doi: 10.1373/clinchem.2010.153486.
  • Irfan A, Reichlin T, Twerenbold R, et al. Early diagnosis of myocardial infarction using absolute and relative changes in cardiac troponin concentrations. Am J Med. 2013;126(9):781.e2–788.e2. doi: 10.1016/j.amjmed.2013.02.031.
  • Simpson P, Tirimacco R, Cowley P, et al. A comparison of cardiac troponin T delta change methods and the importance of the clinical context in the assessment of acute coronary syndrome. Ann Clin Biochem. 2019;56(6):701–707. doi: 10.1177/0004563219876671.
  • Haaf P, Drexler B, Reichlin T, et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation. 2012;126(1):31–40. doi: 10.1161/CIRCULATIONAHA.112.100867.
  • Kim JW, Kim H, Yun Y-M, et al. Absolute change in high-sensitivity cardiac troponin I at three hours after presentation is useful for diagnosing acute myocardial infarction in the emergency department. Ann Lab Med. 2020;40(6):474–480. doi: 10.3343/alm.2020.40.6.474.
  • Ravanavena A, Ravindra C, Igweonu-Nwakile EO, et al. Absolute versus relative changes in cardiac troponins in the diagnosis of myocardial infarction: a systematic review and meta-analysis. Cureus. 2022;14(7):e27414. doi: 10.7759/cureus.27414.
  • Stoyanov KM, Hund H, Biener M, et al. RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2020;9(1):39–51. doi: 10.1177/2048872619861911.
  • Haller PM, Boeddinghaus J, Neumann JT, et al. Performance of the ESC 0/1-h and 0/3-h algorithm for the rapid identification of myocardial infarction without ST-elevation in patients with diabetes. Diabetes Care. 2020;43(2):460–467. doi: 10.2337/dc19-1327.
  • Badertscher P, Boeddinghaus J, Twerenbold R, et al. Direct comparison of the 0/1h and 0/3h algorithms for early rule-out of acute myocardial infarction. Circulation. 2018;137(23):2536–2538. doi: 10.1161/CIRCULATIONAHA.118.034260.
  • Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172(16):1211–1218. doi: 10.1001/archinternmed.2012.3698.
  • Reichlin T, Twerenbold R, Wildi K, et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ. 2015;187(8):E243–E252. doi: 10.1503/cmaj.141349.
  • Mueller C, Giannitsis E, Christ M, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med. 2016;68(1):76.e4–87.e4. doi: 10.1016/j.annemergmed.2015.11.013.
  • Twerenbold R, Neumann JT, Sörensen NA, et al. Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction. J Am Coll Cardiol. 2018;72(6):620–632. doi: 10.1016/j.jacc.2018.05.040.
  • Lambrakis K, Papendick C, French JK, et al. Late outcomes of the RAPID-TnT randomized controlled trial: 0/1-hour high-sensitivity troponin T protocol in suspected ACS. Circulation. 2021;144(2):113–125. doi: 10.1161/CIRCULATIONAHA.121.055009.
  • Reichlin T, Cullen L, Parsonage WA, et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med. 2015;128(4):369–379.e4. doi: 10.1016/j.amjmed.2014.10.032.
  • Rubini Gimenez M, Twerenbold R, Jaeger C, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015;128(8):861.e4–870.e4. doi: 10.1016/j.amjmed.2015.01.046.
  • Boeddinghaus J, Twerenbold R, Nestelberger T, et al. Clinical validation of a novel high-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction. Clin Chem. 2018;64(9):1347–1360. doi: 10.1373/clinchem.2018.286906.
  • Jaeger C, Wildi K, Twerenbold R, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J. 2016;171(1):92–102. doi: 10.1016/j.ahj.2015.07.022.
  • Boeddinghaus J, Nestelberger T, Twerenbold R, et al. High-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction. Clin Chem. 2019;65(7):893–904. doi: 10.1373/clinchem.2018.300061.
  • Boeddinghaus J, Twerenbold R, Nestelberger T, et al. Clinical use of a new high-sensitivity cardiac troponin I assay in patients with suspected myocardial infarction. Clin Chem. 2019;65(11):1426–1436. doi: 10.1373/clinchem.2019.304725.
  • Boeddinghaus J, Nestelberger T, Koechlin L, et al. Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I. J Am Coll Cardiol. 2020;75(10):1111–1124. doi: 10.1016/j.jacc.2019.12.065.
  • Neumann JT, Sörensen NA, Rübsamen N, et al. Evaluation of a new ultra-sensitivity troponin I assay in patients with suspected myocardial infarction. Int J Cardiol. 2019;283:35–40. doi: 10.1016/j.ijcard.2018.12.001.
  • Sörensen NA, Neumann JT, Ojeda F, et al. Diagnostic evaluation of a high-sensitivity troponin I point-of-care assay. Clin Chem. 2019;65(12):1592–1601. doi: 10.1373/clinchem.2019.307405.
  • Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi: 10.1093/eurheartj/ehaa575.
  • Neumann JT, Twerenbold R, Ojeda F, et al. Application of High-Sensitivity troponin in suspected myocardial infarction. N Engl J Med. 2019;380(26):2529–2540. doi: 10.1056/NEJMoa1803377.
  • Khan E, Lambrakis K, Blyth A, et al. Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile. Eur Heart J Acute Cardiovasc Care. 2021;10(9):1038–1047. doi: 10.1093/ehjacc/zuab040.
  • Ljung L, Lindahl B, Eggers KM, et al. A rule-out strategy based on high-sensitivity troponin and HEART score reduces hospital admissions. Ann Emerg Med. 2019;73(5):491–499. doi: 10.1016/j.annemergmed.2018.11.039.
  • Sanchis J, Valero E, García Blas S, et al. Undetectable high-sensitivity troponin in combination with clinical assessment for risk stratification of patients with chest pain and normal troponin at hospital arrival. Eur Heart J Acute Cardiovasc Care. 2020;9(6):567–575. doi: 10.1177/2048872620907539.
  • Pickering JW, Greenslade JH, Cullen L, et al. Assessment of the european society of cardiology 0-hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction. Circulation. 2016;134(20):1532–1541. doi: 10.1161/CIRCULATIONAHA.116.022677.
  • Jaffe AS, White H. Ruling-in myocardial injury and ruling-out myocardial infarction with the european society of cardiology 1-hour algorithm. Circulation. 2016;134(20):1542–1545. doi: 10.1161/CIRCULATIONAHA.116.024687.
  • Vigen R, Kutscher P, Fernandez F, et al. Evaluation of a novel rule-out myocardial infarction protocol incorporating high-sensitivity troponin T in a US hospital. Circulation. 2018;138(18):2061–2063. doi: 10.1161/CIRCULATIONAHA.118.033861.
  • Kavsak PA, Clark L, Caruso N, et al. Caution when using high-sensitivity cardiac troponin I assay to rule out acute ischemia: when the Delta to rule in is within analytical variation. Can J Cardiol. 2020;36(7):1161.e11–1161.e12. doi: 10.1016/j.cjca.2020.03.011.
  • Kavsak PA, Don-Wauchope AC, Hill SA, et al. Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms. Clin Chem. 2016;62(6):887–889. doi: 10.1373/clinchem.2016.255448.
  • Kavsak PA, Clark L, Jaffe AS. Effect of repeat measurements of high-sensitivity cardiac troponin on the same sample using the European Society of Cardiology 0-hour/1-hour or 2-hour algorithms for early rule-out and rule-in for myocardial infarction. Clin Chem. 2017;63(6):1163–1165. doi: 10.1373/clinchem.2017.272914.
  • Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412(9–10):748–754. doi: 10.1016/j.cca.2010.12.034.
  • Donato LJ, Wockenfus AM, Katzman BM, et al. Analytical and clinical considerations in implementing the Roche Elecsys troponin T Gen 5 STAT assay. Am J Clin Pathol. 2021;156(6):1121–1129. doi: 10.1093/ajcp/aqab082.
  • Kavsak PA, Hulett M, Worster A. Imprecision and delta criteria for a new ESC 0/2-hour algorithm. Clin Chem. 2022;68(5):721–722. doi: 10.1093/clinchem/hvac026.
  • Fraser CG. Reference change values. Clin Chem Lab Med. 2011;50(5):807–812.
  • Clerico A, Padoan A, Zaninotto M, et al. Clinical relevance of biological variation of cardiac troponins. Clin Chem Lab Med. 2021;59(4):641–652. doi: 10.1515/cclm-2020-1433.
  • Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56(2):254–261. doi: 10.1373/clinchem.2009.132654.
  • Lopez-Ayala P, Nestelberger T, Boeddinghaus J, et al. Novel criteria for the observe-zone of the ESC 0/1h-hs-cTnT algorithm. Circulation. 2021;144(10):773–787. doi: 10.1161/CIRCULATIONAHA.120.052982.
  • Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58(1):219–225. doi: 10.1373/clinchem.2011.171082.
  • Gore MO, Seliger SL, Defilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014;63(14):1441–1448. doi: 10.1016/j.jacc.2013.12.032.
  • Apple FS, Wu AHB, Sandoval Y, et al. Sex-specific 99th percentile upper reference limits for high sensitivity cardiac troponin assays derived using a universal sample bank. Clin Chem. 2020;66(3):434–444. doi: 10.1093/clinchem/hvz029.
  • Normann J, Mueller M, Biener M, et al. Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J. 2012;164(5):698–705.e4. doi: 10.1016/j.ahj.2012.08.003.
  • Parikh RH, Seliger SL, deFilippi CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem. 2015;48(4–5):247–253. doi: 10.1016/j.clinbiochem.2015.01.004.
  • Boeddinghaus J, Nestelberger T, Twerenbold R, et al. Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction. Eur Heart J. 2018;39(42):3780–3794. doi: 10.1093/eurheartj/ehy514.
  • Miller-Hodges E, Anand A, Shah ASV, et al. High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation. 2018;137(5):425–435. doi: 10.1161/CIRCULATIONAHA.117.030320.
  • Olivieri F, Galeazzi R, Giavarina D, et al. Aged-related increase of high sensitive troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mech Ageing Dev. 2012;133(5):300–305. doi: 10.1016/j.mad.2012.03.005.
  • Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32(11):1379–1389. doi: 10.1093/eurheartj/ehr033.
  • Rubini Giménez M, Twerenbold R, Boeddinghaus J, et al. Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction. JAMA Cardiol. 2016;1(8):912–920. doi: 10.1001/jamacardio.2016.2882.
  • Mueller-Hennessen M, Lindahl B, Giannitsis E, et al. Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T – sub-analysis from the TRAPID-AMI study. Int J Cardiol. 2016;209:26–33. doi: 10.1016/j.ijcard.2016.01.213.
  • Eggers KM, Jernberg T, Lindahl B. Prognostic importance of sex-specific cardiac troponin T 99(th) percentiles in suspected acute coronary syndrome. Am J Med. 2016;129(8):880.e1–e12. doi: 10.1016/j.amjmed.2016.02.047.
  • Moehring B, Mueller M, Rubini Gimenez M, et al. Impact of gender-specific reference values of high-sensitivity troponin T on the prevalence and long-term outcome of acute myocardial infarction. Eur Heart J. 2013;34(Suppl 1):P4042. doi: 10.1093/eurheartj/eht309.P4042.
  • Cullen L, Greenslade JH, Carlton EW, et al. Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain. Heart. 2016;102(2):120–126. doi: 10.1136/heartjnl-2015-308506.
  • Mueller T, Egger M, Peer E, et al. Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting – Results from the linz troponin (LITROP) study. Clin Chim Acta. 2018;487:66–74. doi: 10.1016/j.cca.2018.09.026.
  • Bohula May EA, Bonaca MP, Jarolim P, et al. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome. Clin Chem. 2014;60(1):158–164. doi: 10.1373/clinchem.2013.206441.
  • McRae A, Graham M, Abedin T, et al. Sex-specific, high-sensitivity cardiac troponin T cut-off concentrations for ruling out acute myocardial infarction with a single measurement. CJEM. 2019;21(1):26–33. doi: 10.1017/cem.2018.435.
  • de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304(22):2503–2512. doi: 10.1001/jama.2010.1768.
  • McKie PM, Heublein DM, Scott CG, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59(7):1099–1107. doi: 10.1373/clinchem.2012.198614.
  • Apple FS, Simpson PA, Murakami MM. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin Biochem. 2010;43(12):1034–1036. doi: 10.1016/j.clinbiochem.2010.05.014.
  • Chenevier-Gobeaux C, Meune C, Freund Y, et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Am J Cardiol. 2013;111(12):1701–1707. doi: 10.1016/j.amjcard.2013.02.024.
  • Twerenbold R, Wildi K, Jaeger C, et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation. 2015;131(23):2041–2050. doi: 10.1161/CIRCULATIONAHA.114.014245.
  • Kraus D, von Jeinsen B, Tzikas S, et al. Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease. J Am Heart Assoc. 2018;7(19):e008032. doi: 10.1161/JAHA.117.008032.
  • Than MP, Pickering JW, Sandoval Y, et al. Machine learning to predict the likelihood of acute myocardial infarction. Circulation. 2019;140(11):899–909. doi: 10.1161/CIRCULATIONAHA.119.041980.
  • Liu L, Cai X, Love T, et al. Using logistic regression models to investigate the effects of high-sensitivity cardiac troponin T confounders on ruling in acute myocardial infarction. Clin Chem Lab Med. 2023;61(7):1335–1342. doi: 10.1515/cclm-2022-1004.
  • Lippi G, Cervellin G. Identification of troponin determinants for improving its diagnostic performance in the emergency department. J Emerg Med. 2012;43(6):e487–e488. doi: 10.1016/j.jemermed.2012.05.016.
  • Ashburn NP, Snavely AC, O'Neill JC, et al. Performance of the european society of cardiology 0/1-hour algorithm with high-sensitivity cardiac troponin T among patients with known coronary artery disease. JAMA Cardiol. 2023;8(4):347–356. doi: 10.1001/jamacardio.2023.0031.
  • Liu Y, Wang Y, Huang C, et al. Estimating personalized diagnostic rules depending on individualized characteristics. Stat Med. 2017;36(7):1099–1117. doi: 10.1002/sim.7182.
  • Lippi G, Cervellin G. Letter by lippi and cervellin regarding article, optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation. 2016;133(5):e374. doi: 10.1161/CIRCULATIONAHA.115.018157.
  • Frankenstein L, Wu AH, Hallermayer K, et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem. 2011;57(7):1068–1071. doi: 10.1373/clinchem.2010.158964.
  • Boeddinghaus J, Reichlin T, Cullen L, et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction by use of high-sensitivity cardiac troponin I. Clin Chem. 2016;62(3):494–504. doi: 10.1373/clinchem.2015.249508.
  • Nestelberger T, Boeddinghaus J, Greenslade J, et al. Two-hour algorithm for rapid triage of suspected acute myocardial infarction using a high-sensitivity cardiac troponin I assay. Clin Chem. 2019;65(11):1437–1447. doi: 10.1373/clinchem.2019.305193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.